Global Gateway Advisors is a communications consultancy focused on helping companies, nonprofits, organizations and governments to establish, grow, enhance and protect their reputation through dialogue and influencer engagement.

News

Wages are rising fastest in these US cities

2018-10-29

Fox Business:  As wages start to show signs of increasing, some workers are seeing changes faster than others. Median pay among U.S. workers was $52,746 in October, according to job search site Glassdoor, a 2.4 percent year-over-year increase. Workers in some occupations, like bank tellers, bartenders, maintenance workers and pharmacy technicians saw wage growth that outpaced their peers. Manufacturing workers also saw strong wage gains. But depending on where workers are located, they could experience bumps in their salaries more quickly.

Johnson & Johnson to open JLABS virtual networking pod in Philadelphia

2018-10-29

FierceBiotech:  Johnson & Johnson is broadening access to its startup incubator program with a new remote networking hub called the JPOD, hosted by the University of Pennsylvania. The university’s Pennovation Center in Philadelphia will allow for video conferencing between JLABS entrepreneurs and their J&J gurus across the company’s global network, including developers of pharmaceuticals, medical devices and digital health technologies. “They already have the lab space—which JLABS normally provides—but they were very keen to partner with us on the additional things that are a part of being in JLABS, which is the mentoring, the investing hub and the programming,” said J&J’s Kate Merton.

Red pill or blue? It could be a billion-dollar decision

2018-10-29

BioPharma Dive:  Drug manufacturers and marketers increasingly consider how color, whether in a logo, a campaign, or the drug itself, may best serve a patient's needs and elicit the emotions brand developers want to connect to the product. But introducing new colors can lead to costly delays. Nicolas Madit, Business Development Manager at Lonza Pharma & Biotech, describes how Lonza’s new Colorista technology uses special capsules that contain between 50 and 150 colorants, allowing clients to still meet regulatory guidelines while also proving flexibility to pharma companies and marketers.

Why Europe is ascendant in the pharmaceutical chemical business

2018-10-28

Chemical & Engineering News:  The pharmaceutical service sector remains a global industry. But managers of contract development and manufacturing organizations (CDMOs) who convened in Madrid gave credence to the notion that the business of making custom APIs for new drugs has largely resettled with European firms. Lee Newton, Vice President of API Development and Manufacturing at Lonza, explains how Lonza is working to capitalize on the trend with a new program to offer intermediates made at its facility in Visp, Switzerland, to customers that in the past might have acquired them from farther afield.

Exec Chat: Billy Cohn Talks About His J&J Play In Texas

2018-10-10

Medtech Insight:  Willian E. “Billy” Cohn, surgeon and serial device inventor, has been getting Johnson & Johnson's Center for Device Innovation off the ground this year on the vast Texas Medical Center complex, and he says it's like nothing he has ever experienced. Clinical facilities, doctors and engineers are crucial resources for any surgical medical device start-up pursuing disruptive innovation, and Cohn says he has them in multitudes in his new gig.

How to Climb the Career Jungle Gym… While Constructing the Rungs

2018-09-25

Thrive Global:  In the piece, Rebekah Bastian, VP, Community & Culture at Zillow Group, discusses her career change, transitioning from leading product development at Zillow Group to leading the company’s new Community & Culture organization.

CDRH, MDIC Look to Global Application for NEST

2018-09-24

Regulatory Affairs Professionals Society:  With the first version of the National Evaluation System for health Technology (NEST) set to open for business by the end of 2019, the shared vision among management at the US Food and Drug Administration (FDA) has expanded to a global scope. “Regulators are always looking for scientific proof that your device does what you say it's going to do and is as safe as you say it is,” chair of the NEST Coordinating Center (NESTcc) Michelle McMurry-Heath told Focus at the 2018 MedTech Conference in Philadelphia. That scientific proof, however, evolves with the technology and there are different methods device firms take to test innovation, she added. McMurry-Health—Johnson & Johnson’s worldwide VP of regulatory and clinical affairs and global head of evidence generation—took the helm at the NESTcc earlier this month after serving as the associate director for science at FDA’s Center for Devices and Radiological Health (CDRH).